Freenome

Computational Biologist I

Freenome  •  $131k - $190k/yr  •  Remote  •  2 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

About this opportunity:

At Freenome, we are seeking a Computational Biologist I, Assay Development to help grow the Freenome’s Computational Biology, Assay Development (CBAD) team (can be a Senior Computational Biologist role depending on experience). As part of our team, you will apply your scientific expertise to the development of early, noninvasive tests for cancer detection. With a strong background in bioinformatics, statistics, and molecular biology, you will develop, write, and execute analysis plans and reports for the development and characterization of Freenome’s in vitro diagnostic devices and regulatory filings. You will work closely and cross-functionally with many teams, including Regulatory and Quality, Molecular Research and Development, Laboratory Operations, Biostatistics, Computational Science, and Engineering to enable the successful development of multiple molecular assays as part of Freenome’s diagnostic products.

The role reports to Aaron Richardson. This position can be a hybrid or fully remote role.

What you’ll do:

  • Plan and execute development experiments for Freenome’s multiomics cancer screening tests.
  • Partner cross-functionally with computational, development, regulatory, and quality leaders to develop and execute a regulated development strategy working toward FDA approval.
  • Use your quantitative skills to develop computational methods and interpret complex experimental results in order to optimize and validate innovative technology for sample collection, preparation, and detection.
  • Develop and execute appropriate experimental design and analysis plans for Development, Verification, and Validation studies, closely partnering with Biostatistics, Development, and Pre-Analytics teams.
  • Work closely with molecular and computational research teams developing Freenome’s IVD products for blood-based molecular assays including cell-free DNA, proteins, and additional biomarkers.
  • Impact patient lives through the development and launch of high quality cancer screening technologies

Must haves:

  • Post-graduate degree (MS or PhD) in statistics, computational biology, bioinformatics, cancer biology, or related quantitative field.
  • 2-3+ years of industry experience (for Sr. Scientist level)
  • Experience in experimental design and analysis of high-throughput, quantitative technologies in genomics, epigenomics, transcriptomics, or proteomics (e.g. target capture with UMI, Hi-C, ATAC-seq, RNA-seq, bisulfite sequencing, microarrays, mass spec, immunoassays).
  • Familiarity with and ability to select and leverage bioinformatics tools for the above molecular assays.
  • Experience in applied statistics, such as in hypothesis testing, regression techniques, and appropriate use of simulation.
  • Expertise in data analysis and visualization using R (tidyverse), or Python statistical packages (Numpy, Matplotlib, Pandas), or equivalent, under version control.
  • Excellent oral and written communication skills to communicate to scientific and broader audiences, with keen attention to detail.
  • Ability to work on a cross-functional team in our highly collaborative environment, working with both computational and experimental scientists.

Nice to haves:

  • Experience in the development of diagnostic devices in a regulated environment (PMA, 510(k), CE-IVD) preferred (for Sr. Scientist level).

Benefits and additional information:

The US target range of our base salary for new hires is $131,325 - $189,525. You will also be eligible to receive equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.

Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.

Applicants have rights under Federal Employment Laws.

California applicants please review the CCPA Notice at Collection here:

#LI-Remote

Freenome

About Freenome

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.

To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas.

We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures.

A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

Industry
Biotech & Life Sciences
Company Size
201-500 employees
Headquarters
Brisbane, California
Year Founded
2014
Social Media